Oral anticoagulation in elderly adults with atrial fibrillation: Integrating new options with old concepts

Ignatius Gerardo E Zarraga, Jack Kron

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and the second most common cardiovascular condition in adults in the United States. It is prevalent in the elderly population and is an important risk factor for stroke. Oral anticoagulation offers significant protection against AF-related thromboembolic events, but several complex issues that contribute to its underuse in elderly adults surround it. To aid clinicians in their approach to these problems, a comprehensive PubMed-based search of the literature published in English from 1990 through July 2012 was conducted using the following terms or combination of terms: atrial fibrillation, elderly, antiplatelet, anticoagulation, stroke, bleeding, hemorrhage, and falls. Additional references were identified in a manual search of bibliographies in retrieved articles. The data were then synthesized to address the most relevant questions regarding anticoagulation in elderly adults, including fall risk, responsiveness to warfarin, physician perception of risks, and other barriers to the prescription of anticoagulants. Recently proposed risk-stratification schemes for stroke and hemorrhage that could refine the selection of antithrombotic therapy for AF are highlighted. Finally, available data on the use of antiplatelet therapy, warfarin, and new oral anticoagulants (direct thrombin inhibitor and factor Xa inhibitors) in AF are summarized.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalJournal of the American Geriatrics Society
Volume61
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Atrial Fibrillation
Stroke
Warfarin
Hemorrhage
Anticoagulants
Antithrombins
Bibliography
PubMed
Prescriptions
Cardiac Arrhythmias
Physicians
Therapeutics
Population

Keywords

  • anticoagulation
  • antithrombotic
  • atrial fibrillation
  • elderly

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Oral anticoagulation in elderly adults with atrial fibrillation : Integrating new options with old concepts. / Zarraga, Ignatius Gerardo E; Kron, Jack.

In: Journal of the American Geriatrics Society, Vol. 61, No. 1, 01.2013, p. 143-150.

Research output: Contribution to journalArticle

@article{366fcbb88c694b0694c58b4aa406f740,
title = "Oral anticoagulation in elderly adults with atrial fibrillation: Integrating new options with old concepts",
abstract = "Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and the second most common cardiovascular condition in adults in the United States. It is prevalent in the elderly population and is an important risk factor for stroke. Oral anticoagulation offers significant protection against AF-related thromboembolic events, but several complex issues that contribute to its underuse in elderly adults surround it. To aid clinicians in their approach to these problems, a comprehensive PubMed-based search of the literature published in English from 1990 through July 2012 was conducted using the following terms or combination of terms: atrial fibrillation, elderly, antiplatelet, anticoagulation, stroke, bleeding, hemorrhage, and falls. Additional references were identified in a manual search of bibliographies in retrieved articles. The data were then synthesized to address the most relevant questions regarding anticoagulation in elderly adults, including fall risk, responsiveness to warfarin, physician perception of risks, and other barriers to the prescription of anticoagulants. Recently proposed risk-stratification schemes for stroke and hemorrhage that could refine the selection of antithrombotic therapy for AF are highlighted. Finally, available data on the use of antiplatelet therapy, warfarin, and new oral anticoagulants (direct thrombin inhibitor and factor Xa inhibitors) in AF are summarized.",
keywords = "anticoagulation, antithrombotic, atrial fibrillation, elderly",
author = "Zarraga, {Ignatius Gerardo E} and Jack Kron",
year = "2013",
month = "1",
doi = "10.1111/jgs.12042",
language = "English (US)",
volume = "61",
pages = "143--150",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Oral anticoagulation in elderly adults with atrial fibrillation

T2 - Integrating new options with old concepts

AU - Zarraga, Ignatius Gerardo E

AU - Kron, Jack

PY - 2013/1

Y1 - 2013/1

N2 - Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and the second most common cardiovascular condition in adults in the United States. It is prevalent in the elderly population and is an important risk factor for stroke. Oral anticoagulation offers significant protection against AF-related thromboembolic events, but several complex issues that contribute to its underuse in elderly adults surround it. To aid clinicians in their approach to these problems, a comprehensive PubMed-based search of the literature published in English from 1990 through July 2012 was conducted using the following terms or combination of terms: atrial fibrillation, elderly, antiplatelet, anticoagulation, stroke, bleeding, hemorrhage, and falls. Additional references were identified in a manual search of bibliographies in retrieved articles. The data were then synthesized to address the most relevant questions regarding anticoagulation in elderly adults, including fall risk, responsiveness to warfarin, physician perception of risks, and other barriers to the prescription of anticoagulants. Recently proposed risk-stratification schemes for stroke and hemorrhage that could refine the selection of antithrombotic therapy for AF are highlighted. Finally, available data on the use of antiplatelet therapy, warfarin, and new oral anticoagulants (direct thrombin inhibitor and factor Xa inhibitors) in AF are summarized.

AB - Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and the second most common cardiovascular condition in adults in the United States. It is prevalent in the elderly population and is an important risk factor for stroke. Oral anticoagulation offers significant protection against AF-related thromboembolic events, but several complex issues that contribute to its underuse in elderly adults surround it. To aid clinicians in their approach to these problems, a comprehensive PubMed-based search of the literature published in English from 1990 through July 2012 was conducted using the following terms or combination of terms: atrial fibrillation, elderly, antiplatelet, anticoagulation, stroke, bleeding, hemorrhage, and falls. Additional references were identified in a manual search of bibliographies in retrieved articles. The data were then synthesized to address the most relevant questions regarding anticoagulation in elderly adults, including fall risk, responsiveness to warfarin, physician perception of risks, and other barriers to the prescription of anticoagulants. Recently proposed risk-stratification schemes for stroke and hemorrhage that could refine the selection of antithrombotic therapy for AF are highlighted. Finally, available data on the use of antiplatelet therapy, warfarin, and new oral anticoagulants (direct thrombin inhibitor and factor Xa inhibitors) in AF are summarized.

KW - anticoagulation

KW - antithrombotic

KW - atrial fibrillation

KW - elderly

UR - http://www.scopus.com/inward/record.url?scp=84872273073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872273073&partnerID=8YFLogxK

U2 - 10.1111/jgs.12042

DO - 10.1111/jgs.12042

M3 - Article

C2 - 23252345

AN - SCOPUS:84872273073

VL - 61

SP - 143

EP - 150

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 1

ER -